Company · CIK 0001444192 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Grace Therapeutics, Inc. · GRCE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 PForm 4 → | Sep 23, 6:19 pm EDT | Opaleye Management Inc.10% Owner | 15,089 | $2.10 | $31,687 | 2,855,318 | +0.53% | |
| Sep 9, 2026 PForm 4 → | Sep 10, 7:30 am EDT | Prashant KohliChief Executive Officer, Director | 100,000 | $2.14 | $214,000 | 121,357 | +468% | |
| Sep 8, 2026 PForm 4 → | Sep 10, 4:05 pm EDT | Opaleye Management Inc.10% Owner | 15,229 | $2.09 | $31,896 | 2,775,229 | +0.55% | |
| Aug 14, 2026 PForm 4 → | Aug 19, 7:44 am EDT | Opaleye Management Inc.10% Owner | 11,608 | $2.09 | $24,206 | 2,760,000 | +0.42% | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 AForm 4 → | Sep 21, 4:22 pm EDT | Edward NeugeborenDirector | 12,200 | — | — | 12,200 | — | |
| Sep 17, 2026 AForm 4 → | Sep 21, 4:20 pm EDT | A Brian DavisDirector | — | — | — | 12,200 | — | |
| Sep 17, 2026 AForm 4 → | Sep 21, 4:15 pm EDT | Vimal KavuruDirector | 12,200 | — | — | 12,200 | — | |
| Sep 17, 2026 AForm 4 → | Sep 21, 4:13 pm EDT | George KottayilDirector | 12,200 | — | — | 12,200 | — | |
| Aug 28, 2026 AForm 4 → | Sep 1, 4:05 pm EDT | Amresh KumarVP Program Management | 35,760 | — | — | 35,760 | — | |
| Aug 28, 2026 AForm 4 → | Sep 1, 4:05 pm EDT | Prashant KohliChief Executive Officer, Director | 267,160 | — | — | 267,160 | — | |
| Aug 28, 2026 AForm 4 → | Sep 1, 4:05 pm EDT | R. Loch MacdonaldChief Medical Officer | 54,690 | — | — | 54,690 | — | |
| Aug 28, 2026 AForm 4 → | Sep 1, 4:05 pm EDT | Robert J DelAversanoPrincipal Financial Officer | 33,660 | — | — | 33,660 | — |